3 No-Brainer Biotech Stocks to Buy With 200 Right Now - Yahoo Finance
| 0A3M Stock | USD 109.00 4.00 3.54% |
About 62% of BioNTech's investor base is looking to short. The analysis of the overall investor sentiment regarding BioNTech SE suggests that many traders are alarmed. BioNTech's investing sentiment shows overall attitude of investors towards BioNTech SE.
BioNTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioNTech daily returns and investor perception about the current price of BioNTech SE as well as its diversification or hedging effects on your existing portfolios.
BioNTech |
3 No-Brainer Biotech Stocks to Buy With 200 Right Now Yahoo Finance
Read at news.google.com
 |
BioNTech Fundamental Analysis
We analyze BioNTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
BioNTech is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
BioNTech SE Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
Peers
BioNTech Related Equities
| TYT | Toyota | 1.74 | ||||
| 0R15 | SoftBank Group | 1.42 | ||||
| 0R2O | Freeport McMoRan | 0.87 | ||||
| 0QYD | Yum Brands | 0.79 | ||||
| 0HF7 | Ametek | 0.66 | ||||
| 0QY4 | Las Vegas | 0.56 | ||||
| 0KS2 | Public Service | 0.22 | ||||
| 0M69 | OTP Bank | 0.00 | ||||
| 0RR8 | Baker Hughes | 0.39 | ||||
| 0KCI | ONEOK | 0.68 |
Check out BioNTech Hype Analysis, BioNTech Correlation and BioNTech Performance. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.